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A B S T R A C T
Purpose: There is currently no resective (potentially curative) surgical option that is useful in patients
with Lennox–Gastaut syndrome. Palliative procedures such as callosotomy (Cx), vagus nerve stimulation
(VNS) or deep brain stimulation have been offered. We compared the outcomes after Cx or VNS in two
consecutive prospective cohorts of patients with generalised epilepsy.
Methods: Twenty-four patients underwent callosotomy from 2006 to 2007 (Group 1); 20 additional
patients were submitted to VNS from 2008 to 2009 (Group 2). They had generalised epilepsy of the
Lennox–Gastaut or Lennox-like type. They were submitted to a neurological interview and
examination, interictal and ictal video-EEG, high resolution 1.5 T MRI, and cognitive and quality of
life evaluations. The two-year post-operative follow-up results were evaluated for each patient.
Results: The ﬁnal mean stimuli intensity was 3.0 mA in the Group 2 patients. Seizure-free patients
accounted for 10% in Group 1 and none in Group 2. Ten and sixteen percent of the Group 1 and 2 patients,
respectively, were non-responders. Improvements in attention and quality of life were noted in 85% of
both Group 1 and 2 patients. Rupture of the secondary bilateral synchrony was noted in 85% of Group
1 patients; there was no EEG modiﬁcation after VNS in Group 2. Both procedures were effective
regarding the control of atypical absences and generalised tonic–clonic seizures. Both procedures
were not effective in controlling tonic seizures. Callosotomy was very effective in reducing the
frequency of atonic seizures, but VNS was ineffective. In contrast, callosotomy was not effective in
reducing myoclonic seizures, whereas VNS was.
Discussion: Callosotomy might be preferred as the primary treatment in children with Lennox–Gastaut
syndrome, and no speciﬁc ﬁndings on MRI if atonic seizures prevail in the patient’s clinical picture; when
myoclonic seizures prevail, the same might hold true in favour of VNS. When atypical absence or
generalised tonic–clonic seizures are the main concern, although both procedures carry similar
effectiveness, VNS might be considered a good option as an initial approach, taking into account the
adverse event proﬁle. Patients should be advised that both procedures are not very effective in the
treatment of tonic seizures.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Patients with generalised epilepsy have multiple seizure types,
mental retardation, and diffuse EEG abnormalities and are often
refractory to medical treatment. There is currently no resective
(potentially curative) surgical option useful in this patient
population. Palliative procedures, such as callosotomy (Cx),1–3* Corresponding author at: Clinica de Epilepsia de Sao Paulo, R Dr Alceu de
Campos Rodrigues 247 # 121, Sao Paulo, SP, CEP 04544-000, Brazil.
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1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.02.009vagus nerve stimulation (VNS)4–6 and more recently deep brain
stimulation,7 have been offered.
Some authors tried to directly compare the effectiveness of
callosotomy versus VNS in patients with generalised epilepsy8–10
and noted that additional data would be mandatory to further
discuss the issue. We compared the outcomes after Cx or VNS in
two consecutive prospective cohorts of patients with generalised
epilepsy.
2. Methods
Forty-four consecutive patients with refractory generalised
epilepsy were studied. Twenty-four patients were submitted tovier Ltd. All rights reserved.
Table 1
Demographic analysis for the present series (chi-square). There was no difference
regarding any of the above variables. Freq: frequency; Perc: percentage; (p): ‘‘p’’
value.
Variable Category Group (p)
VNS Cx
Freq. Perc. Freq. Perc.
Gender Female 5 20.80% 9 45.00% 0.087
Male 19 79.20% 11 55.00%
Atrophy on MRI No 9 37.50% 6 30.00% 0.601
Yes 15 62.50% 14 70.00%
Gliosis on MRI No 15 62.50% 14 70.00% 0.601
Yes 9 37.50% 6 30.00%
Generalised EEG No 0 0.00% 0 0.00% >0.999
Yes 24 100.00% 20 100.00%
Mental retardation No 0 0.00% 0 0.00% >0.999
Yes 24 100.00% 20 100.00%
A. Cukiert et al. / Seizure 22 (2013) 396–400 397callosotomy from 2006 to 2007 (Group 1); twenty additional
patients were submitted to VNS from 2008 to 2009 (Group 2).
There were no intervening patients: no patient with such a
diagnosis had VNS from 2007 to 2008, and no patient had
callosotomy from 2008 to 2009.
They were submitted to a neurological interview and exami-
nation, interictal and ictal video-EEG, high resolution 1.5 T MRI,
and cognitive and quality of life evaluations. Information regarding
the age at seizure onset, age at surgery, type and frequency of
seizure types, stimulation parameters (for Group 2 patients), EEG
ﬁndings, and epileptic syndrome type was obtained. They had
generalised epilepsy of the Lennox–Gastaut or Lennox-like type,
including multiform (atonic, myoclonic, tonic–clonic, tonic, and
atypical absence) daily seizures, mental retardation and general-
ised EEG ﬁndings. A full age-compatible neuropsychological
examination was attempted. Surface 32-channel video-EEG using
the 10–20 electrode system was obtained, and at least 3 habitual
seizures were recorded preoperatively. The parents or caregivers
kept a seizure diary. A pre-operative mean (3 months) daily seizure
frequency was obtained, and the children were followed up every 2
months post-operatively.
The MRI examination included T1 and T2 and FLAIR axial,
coronal and sagittal thin slices. The quality of life information was
gathered using QOLIE-31,11 and the attention-level evaluation was
based on the attention-related part of the SNAP-IV questionnaire12
(18 items), to which an extra question regarding verbal ﬂuency
was added. The anti-epileptic drug dosages were kept stable
throughout the study.
Group 1 patients were submitted to a maximised callosal
section (90%), which was performed as a one-stage procedure
under general anaesthesia. After positioning the head in such a way
that the body of the corpus callosum would be perpendicular to the
ﬂoor (as seen on a midsagittal MRI scan), a right frontal craniotomy
centred over the coronal suture was performed. After opening the
dura mater, the interhemispheric ﬁssure was dissected, and the
corpus callosum was exposed. The anterior half of the corpus
callosum was sectioned under direct vision using the surgical
microscope. The posterior portion of the corpus callosum was then
aspirated using an intracallosal suction technique, leaving only the
splenium in place. While performing the aspiration of the posterior
portion of the callosum, the surgeon followed the intrinsic
anatomy of this structure, which usually included thinning of
the callosal body at the midparietal topography followed by an
increase in its diameter before reaching the splenium (this
anatomical feature could also be foreseen from individual
midsagittal MR scans). The section was terminated when the
posterior cingulate cortex was identiﬁed. A post-operative MRI
conﬁrmed the extent of the section.
Group 2 patients underwent left vagus nerve stimulator
implantation under general anaesthesia. Intra-operative testing
of the device was performed, but the generator remained off until
stitches were out (3 weeks) and the seizure frequency was similar
to baseline. The generator was turned on using the parameters of
0.25 mA, 30 Hz, 500 ms, 30 s ‘‘on’’, and 5 min ‘‘off’’; the current was
then increased by 0.25 mA every 2 weeks until 3.5 mA was
reached or adverse effects were noted. The current intensity was
lowered 0.5 mA if any adverse event presumably related to the
prior current increase was noted, and a second attempt to increase
the current was made 1 month later. If an adverse effect occurred
again, the current was maintained at the maximally tolerated
level.
Patients with a speciﬁc aetiology (e.g., cortical dysplasia and
tuberous sclerosis) were excluded from the study. Children with
previous surgical procedures, neck anatomical abnormalities or
variations (for Group 2), absent or very thin corpus callosum (for
Group 1), systemic diseases that might affect the surgery orparents/caregivers who were unable to adequately keep the
seizure diary were excluded from the study.
Patients with at least a 50% reduction in the frequency of a
speciﬁc seizure type were considered responders regarding that
seizure type.
The statistical analysis was performed using chi-square, Mann–
Whitney or Fisher’s exact testing where appropriate (a ‘‘p’’ value
lower then 0.05 was considered signiﬁcant). The two-year post-
operative follow-up results were evaluated for each patient.
3. Results
The mean age of seizure onset was 2.8  1.6 and 2.88  1.4 years
for Groups 1 (55% males) and 2 (80% males), respectively. The mean
age at surgery was 11.2  3.3 and 8.6  3.2 years for Groups 1 and 2,
respectively. Fifteen and twelve patients were diagnosed as having
Lennox–Gastaut syndrome in Groups 1 and 2, respectively; the
remaining patients in each group were diagnosed as having Lennox-
like syndrome (all clinical and EEG features of Lennox–Gastaut
syndrome without the EEG-recruiting rhythm during sleep). The MRI
showed cortico-subcortical atrophy in 70% of Group 1 and 62.5% of
Group 2 patients; non-speciﬁc gliosis was present in the remaining
patients (Tables 1 and 2).
All patients had multiple seizure types: 15% and 55% had 2
seizure types in Groups 1 and 2, respectively; 30% and 20% had 3
seizure types in Groups 1 and 2, respectively; and 55% and 25%
had 4 seizure types in Groups 1 and 2, respectively. Tonic
seizures were present in 55% and 20% of the patients in Groups 1
and 2, respectively; atonic seizures in 75% and 20% of Groups 1
and 2, respectively; myoclonic seizures in 50% and 40% of Groups
1 and 2, respectively; generalised tonic–clonic seizures in 55% of
both Groups 1 and 2; and atypical absence in 75% and 60% of
Groups 1 and 2, respectively.
Before surgery, the mean daily tonic seizure frequency was
8.4  4.9 (mean  sd) and 8.6  6.1 in Groups 1 and 2, respectively;
the mean atonic daily seizure frequency was 10.0  5.7 and 9.3  5.2
in Groups 1 and 2, respectively; the mean myoclonic daily seizure
frequency was 37.0  18.0 and 27.0  18.2 in Groups 1 and 2,
respectively; the mean generalised tonic–clonic daily seizure
frequency was 7.0  3.5 and 8.0  6.2 in Groups 1 and 2, respectively;
and the mean atypical absence daily seizure frequency was 25.0  9.7
and 15.0  8.1 in Groups 1 and 2, respectively. After surgery, the
mean daily tonic seizure frequency was 6.9  2.3 and 7.8  5.9 in
Groups 1 and 2, respectively; the mean atonic daily seizure frequency
was 1.2  1.2 and 11.6  3.8 in Groups 1 and 2, respectively; the
mean myoclonic daily seizure frequency was 26.0  16.8 and
Table 2
Demographic analysis for the present series (Mann–Whitney). The VNS patients presented at an earlier age. There was no difference regarding the age at seizure onset. Min:
minimum; Max: maximum; (p): ‘‘p’’ value; SD: standard deviation; n: number of patients.
Variable Group n Mean SD Min Max Percentile
25
Percentile
50 (median)
Percentile
75
(p)
Age seizure onset Cx 24 2.88 1.92 0.00 7.00 2.00 2.00 4.00 0.961
VNS 20 2.80 1.67 0.00 7.00 2.00 2.00 4.00
Total 44 2.84 1.79 0.00 7.00 2.00 2.00 4.00
Age at surgery Cx 24 8.63 3.19 4.00 15.00 6.00 8.00 11.00 0.011
VNS 20 11.20 3.02 6.00 16.00 9.00 11.00 14.00
Total 44 9.80 3.34 4.00 16.00 7.00 9.50 12.75
A. Cukiert et al. / Seizure 22 (2013) 396–4003985.3  5.1 in Groups 1 and 2, respectively; the mean generalised tonic–
clonic daily seizure frequency was 2.9  2.4 and 2.0  0.3 in Groups 1
and 2, respectively; and the mean atypical absence daily seizure
frequency was 4.2  2.4 and 7.6  7.2 in Groups 1 and 2, respectively
(Table 3).
The ﬁnal mean stimuli intensity (amplitude) was 3.0 mA
(30 Hz, 500 ms) in the Group 2 patients.
Seizure-free patients accounted for 10% of Group 1 and none of
Group 2. Ten and sixteen percent of the Group 1 and 2 patients,
respectively, were complete non-responders.
Improvements in attention and quality of life were noticed in
85% of the patients in both Groups 1 and 2. Rupture of secondary
bilateral synchrony was noted in 85% of Group 1 patients, and there
was no EEG modiﬁcation after VNS in Group 2. This study was
designed to include neuropsychological data. Unfortunately, most
of the children included in the study were severely mentally
retarded (as is common in such a patient population), and only a
minority were able to undergo formal neuropsychological testing.
Not enough data were available for a formal neuropsychological
analysis.
All but one Group 1 patient disclosed acute callosal
disconnection syndrome immediately postoperatively, consist-
ing of apathy, urinary incontinence and non-dominant hemi-
neglect and lasting for up to 3 weeks; 1 Group 2 patient
presented hoarseness after VNS activation. No major long-
lasting morbidity or mortality occurred in either Group 1 or 2.
The mean hospital stay was 7.5  1.2 (mean  sd) and 2.0  0.3
days in Groups 1 and 2, respectively. The mean stay in the ICU was
2.7  0.3 days in Group 1; the Group 2 patients only stayed
overnight in the ICU. Forty-ﬁve percent of the Group 1 patients
received at least 250 ml of blood transfusion; no blood was
transfused in the Group 2 patients.Table 3
Comparison of the efﬁcacy of each procedure with respect to each seizure type (Fishe
treatment of atonic seizures, whereas vagus nerve stimulation (VNS) was more effectiv
atypical absence, generalised tonic–clonic or tonic seizures. Freq: frequency; Perc: per
Variable Category Group 
VNS 
Freq. 
Atonic seizures Non-responders 4 
Responders 1 
Tonic seizures Non-responders 3 
Responders 2 
Myoclonic seizures Non-responders 4 
Responders 7 
Atypical absence seizures Non-responders 3 
Responders 12 
Generalised tonic–clonic seizures Non-responders 7 
Responders 6 4. Discussion
Our data showed that both procedures were effective regarding
the control of atypical absences and generalised tonic–clonic
seizures, although there was a trend towards better results
regarding atypical absences after Cx. Both procedures were not
effective in controlling tonic seizures. Callosotomy was very
effective in reducing the frequency of atonic seizures, but VNS was
ineffective. In contrast, callosotomy was not effective in reducing
myoclonic seizures, whereas VNS was. We tried to homogenise our
patient population. We included only children with normal MRI
results or diffuse cortico-subcortical atrophy to avoid the possible
confounding effects of different aetiologies that might be
associated with Lennox–Gastaut syndrome.
We reported on two consecutive prospective series of patients
with Lennox–Gastaut type syndrome without any intervening
patients, which although not randomised and time-lapsed, were
treated at the same institution and by the same epilepsy team.
The only signiﬁcant difference in the demographic data was in
the age of presentation for surgery (means of 11.2 and 8.4 years
for callosotomy and VNS, respectively). The age at seizure onset
was similar in both groups. Although the ﬁnding of patients
presenting at an earlier age for surgery denotes some demo-
graphic difference, this trend was also observed in our general
epilepsy surgery series, and as far as the demographics for the
seizure syndrome remain comparable, we do not believe that
such a difference would have a major impact on our results. This
earlier presentation for surgery might represent increased
availability and awareness regarding epilepsy surgery.
Patients submitted to callosotomy (2006–2007) had more
atonic and tonic seizures, although the baseline frequency of each
seizure type was comparable between the groups. Because neitherr’s exact test). Callosotomy (Cx) was signiﬁcantly more effective (p = 0.001) in the
e for myoclonic seizures (p = 0.011). Both procedures had a similar effect regarding
centage; (p): ‘‘p’’ value.
(p)
Cx
Perc. Freq. Perc.
80.00% 1 10% 0.004
20.00% 9 90.00%
60.00% 8 80.00% 0.407
40.00% 2 20.00%
36.40% 9 90.00% 0.017
63.60% 1 10.00%
20.00% 1 7.00% 0.125
80.00% 13 93.00%
53.85% 6 60.00% 0.130
46.15% 4 40.00%
A. Cukiert et al. / Seizure 22 (2013) 396–400 399procedure was effective in treating tonic seizures and callosotomy
was signiﬁcantly more effective then VNS in treating atonic
seizures, this difference likely did not inﬂuence our results.
The methodology of our study is that of two consecutive series
with different surgeries rather than a contemporaneous, random-
ised study. There are inherent biases, known and unknown, that
inﬁltrate consecutive series and limit the ability to draw
conclusions. These include but are not limited to factors such as
the type of patient referred, the drugs available, the experience of
the team, the experience of the referring physicians, the practice of
drug monitoring, and the practice of data or seizure recording.
However, due to operational, logistic, budget, etc. considerations,
we would likely not obtain results from an adequate double-
blinded RCT comparing VNS and callosotomy in the near future.
Such a study might include a 4–5 year recruiting period plus a
minimum 24 months of follow-up time and 1–1.5 years for
manuscript preparation and publishing, such that the best-case
scenario would be results after 7–8 years. The data we present
herein, although the study design might be correctly criticised, will
most likely remain a useful input on this issue for many years.
In this series, we only included children with non-speciﬁc MRI
ﬁndings, trying to avoid eventual differential disease (such as
cortical dysplasia or tuberous sclerosis)-speciﬁc outcomes. Most of
the published individual, non-prospective, non-randomised series
appear to suggest that callosotomy has a better outcome regarding
atonic seizures then VNS, but there is a large heterogeneity with
respect to the quality and pattern of reporting within the series.13–
16 Lancman suggested in a meta-analysis that callosotomy was
more efﬁcacious in the control of atonic seizures, although he was
not able to show any differences within the other seizure types, as
shown in our present series.17 Along the same lines of evidence,
some groups reported that atypical absence and generalised
tonic–clonic seizures were reduced by both VNS and callosotomy.
Our series showed that VNS and callosotomy were ineffective to
reduce the frequency of tonic seizures, although these procedures
were effective in some studies.18–21 In our series, myoclonic
seizures were reduced only after VNS; this ﬁnding was in contrast
to the ﬁndings of some other studies, which suggested that
callosotomy would be able to reduce this type of seizure.22,23
Conversely, in our series, VNS was ineffective in treating atonic
seizures, in contrast to previous ﬁndings suggesting that VNS
might be effective to treat these seizure types.24 Some authors
suggested that there was a progressive improvement of seizure
control over time during VNS,25,26 and others suggested that the
seizure control after callosotomy was lost over time27; in both our
groups, the seizure control rates obtained after one year of follow-
up were stable over time (at least up to the two years of follow-up
that were considered in the present report).
The quality of life and attention improvements were equally
noticed in BOTH Groups. The improvement in attention in patients
submitted to callosal sectioning is usually related to improvements
in seizure frequency28; however, attention improvement was
noted in patients submitted to VNS even though they were
considered poor responders regarding seizure frequency.29,30
Attention improvement after callosotomy might be related to
better cortical functioning (especially within the frontal lobes,
which are densely interconnected by callosal ﬁbres) after
disconnection, and thus directly related to the degree of
improvement in epileptogenesis, whereas attention improvement
after VNS might be related to the activation of deep seated nuclei
related to the ascending reticular system (such as the locus
ceruleus) and not to action upon an anti-epileptic network.
In this series, the EEG pattern modiﬁcations after surgery that
could be observed after visual analysis were noted in almost all
children after callosotomy31 and not in any children after VNS,
although some reports have suggested that VNS might be able toaffect the EEG.32 From a pathophysiological perspective, because
the corpus callosum is the major interhemispheric commissure
and mediates the secondary bilateral synchrony that is character-
istic of the Lennox–Gastaut EEG ﬁndings, the appearance of an
asynchronous interhemispheric post-callosotomy rhythm might
be expected. In contrast, VNS exerts its anti-epileptic action
through the activation of polysynaptic systems and not by acting
directly upon the cortical discharge generators or the commissural
synchronising structures. This action might be related to the
inability of VNS to grossly alter the EEG.
Our ﬁndings reinforce previous beliefs. However, although, as
mentioned above, the present study design has pitfalls, the data
presented carry a higher level of evidence than our basic clinical
feelings (beliefs). We did not have higher morbidity in the
callosotomy series, but this procedure does have a higher
potential morbidity compared with VNS surgery. Longer hospital
stays (including ICU stays), a transient acute disconnection
syndrome and blood transfusions were characteristics of the
Group 1 patients only. Additionally, adequate microsurgical
training and technique is necessary to safely perform extended
callosal sections, whereas the training requirements for VNS are
much lower. Although complications are rare with both proce-
dures, callosotomy carries a much higher risk for severe morbidity
and mortality, which might explain the ‘‘VNS ﬁrst’’ choice
currently preferred in some centres, although there is a limited
technical basis for doing so. We do have to note, however, that
from a practical point of view, we have been very successful in
convincing patients/families/caregivers to go ahead with VNS
after being submitted to callosotomy but have very rarely
succeeded the other way around (‘‘the ﬁrst procedure did not
work, why should we go ahead with a more dangerous one?’’).
Both therapeutic options are presently available in our Centre.
Our data suggested that in children with Lennox–Gastaut
syndrome and no speciﬁc ﬁndings on MRI (such as cortical
dysplasia and tuberous sclerosis), if atonic seizures prevail in the
patient’s clinical picture, callosotomy might be a good option as the
primary treatment, whereas when myoclonic seizures prevail, this
same might hold true in favour of VNS. When atypical absence or
generalised tonic–clonic seizures are the main concern, although
both procedures carry similar effectiveness, VNS might be
considered as the initial approach, taking into account the adverse
event proﬁle. Patients should be advised that both procedures are
not very effective in the treatment of tonic seizures.
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